Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biological Psychiatry|November 26, 2025
Imaging Neuroimmune Dysfunction: From TSPO to Emerging PET TargetsRobin Bonomi, Nakul Raval, Ansel Hillmer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2021
Kinetic modeling and parameter estimation of TSPO PET imaging in the human brainCatriona Wimberley, Sonia Lavisse, Ansel Hillmer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 10, 2021
TSPO imaging in animal models of brain diseasesNadja Van Camp, Sonia Lavisse, Pauline Roost, et al.
Nuclear Medicine and Biology|July 12, 2011
An in vivo comparison of cis- and trans-[18F]mefway in the nonhuman primateDustin Wooten, Ansel Hillmer, Dhanabalan Murali, et al.
Research Square|June 12, 2025
Cannabinoid Receptor Type 1 Availability in Individuals with a History of Childhood Trauma: A Positron Emission Tomography StudyAnahita Bassir Nia, Ardavan Mohammad Aghaei, Brian Pittman, et al.
Research Square|November 24, 2025
A Preliminary Investigation of Brain Cannabinoid Receptor Type 1 (CB1R) Availability in Men with Opioid Use DisorderAnahita Bassir Nia, Ardavan Mohammad Aghaei, Jeremy Weleff, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2019
In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideationMargaret T Davis, Ansel Hillmer, Sophie E Holmes, et al.
Molecules (Basel, Switzerland)|October 17, 2015
A Promising PET Tracer for Imaging of α₇ Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based RadioligandRodrigo Teodoro, Matthias Scheunemann, Winnie Deuther-Conrad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 1, 2019
Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [11C]PBR28 HRRT PET studyJouni Tuisku, Pontus Plavén-Sigray, Edward C Gaiser, et al.
Pageof 1